BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED

BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED is primarily a **commercial and marketing entity**, responsible for the sales, distribution, and promotion of Bristol-Myers Squibb's global pharmaceutical products in India. While its parent company, Bristol-Myers Squibb, is a major global manufacturer of pharmaceuticals, the Indian subsidiary itself functions more as a **distributor and sales organization** rather than a large-scale manufacturing factory in India. They facilitate the availability of global BMS products within the Indian market.

Company Introduction:

BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED is the Indian subsidiary of Bristol-Myers Squibb, a global biopharmaceutical company. Founded with a mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, the company operates in India as a key player in the pharmaceutical sector.

Core Business and Operations:

The primary activities of BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED involve the import, marketing, sales, and distribution of Bristol-Myers Squibb's diverse portfolio of pharmaceutical products across various therapeutic areas. These typically include oncology, immunology, cardiovascular diseases, and neuroscience. The company focuses on bringing cutting-edge treatments to Indian patients, ensuring access to life-changing medications developed through extensive research and development by its global parent.

Role in India:

In India, the company maintains a significant commercial presence, engaging with healthcare professionals, hospitals, and pharmacies to ensure the widespread availability of its specialized medicines. They are also often involved in local clinical trial initiatives, contributing to global research and development efforts and generating local clinical data relevant to the Indian patient population. Their operations are geared towards strengthening the market presence of Bristol-Myers Squibb's brands and delivering on the company's commitment to improving patient outcomes.

Based on available information, Bristol-Myers Squibb India Private Limited focuses on the following therapeutic areas:

* Oncology

* Hematology

* Immunology

Specific product names are not publicly available.